.png)
SummaryABDA is the federal umbrella organisation of German pharmacists, the Bundesvereinigung Deutscher Apothekerverbaende, while ABDATA is a pharmaceutical data service that produces drug databases. They are not the same thing: ABDATA is a business division of Avoxa, the media and data company that ABDA owns, which is why the databases carry the ABDA name.
That one distinction resolves most of the confusion international teams run into when they first work with German medicinal product data. ABDA is an association. It does not sell data. ABDATA is a data producer three levels down the ownership chain, and the products it publishes are branded with the parent association's initials, which is precisely why the two names get mixed up.
This article explains what each organisation actually is, how the three names relate to each other, why the confusion is structural rather than careless, and where these names sit in the wider landscape of German pharmaceutical data. For the products themselves, two companion articles go deeper: the ABDA database family and the ABDA-Artikelstamm article master file.
ABDA is the national representative body of the pharmacy profession in Germany. It was founded on 12 July 1950 and is seated in Berlin. Its full current name is ABDA, Bundesvereinigung Deutscher Apothekerverbaende e.V., which translates roughly as the Federal Union of German Pharmacists' Associations.
Its membership is not made up of individual pharmacists. ABDA is a federation of federations. Its members are the 17 state pharmacists' chambers (Apothekerkammern) and the 17 state pharmacists' associations (Apothekerverbaende), 34 member organisations in total. The count is 17 rather than 16 because North Rhine-Westphalia is divided into two pharmacy districts, Nordrhein and Westfalen-Lippe.
The division of labour between chambers and associations is worth understanding, because it explains ABDA's dual character. Chambers are bodies under public law with statutory responsibility for professional standards, continuing education and professional supervision. Associations are private-law bodies that represent the commercial interests of pharmacy owners, most visibly in negotiations with the statutory health insurance funds. ABDA sits above both, which means it speaks for the profession as a regulator-adjacent standards body and as an economic interest group at the same time.
What ABDA actually does, in practice:
The full list of bodies is published by ABDA itself. The relevant point for anyone working with data is the last two bullets: ABDA is a holding structure as well as a lobby, and one of the things it holds is a commercial data business.
Avoxa, formally Avoxa Mediengruppe Deutscher Apotheker GmbH, is ABDA's media and data subsidiary. It was formed in July 2016 by merging the Werbe- und Vertriebsgesellschaft Deutscher Apotheker mbH with Govi-Verlag Pharmazeutischer Verlag GmbH and parts of the Verwaltungsgesellschaft Deutscher Apotheker. It is headquartered in Eschborn near Frankfurt am Main.
Avoxa is the piece international readers almost never know about, and it is the missing link that makes the naming make sense. Its portfolio spans four quite different businesses:
So the chain is: ABDA the association owns Avoxa the company, and Avoxa the company runs ABDATA the data service. Three names, one lineage.
ABDATA Pharma-Daten-Service is the business division of Avoxa that develops and produces databases on medicinal products and other goods sold through pharmacies. It is not a separate legal entity and it is not a public authority. It is a commercial data producer whose output is licensed to software vendors, who in turn embed it in the systems that pharmacies, hospitals, medical practices, manufacturers, wholesalers and health insurers use every day.
That licensing model is the reason most professionals encounter ABDATA data without ever seeing the ABDATA name. If you use German pharmacy software, hospital pharmacy software or a prescriber system, you are very likely reading ABDATA content rendered inside someone else's interface.
Per ABDATA's own product listing, the portfolio splits along a clean line. One family answers commercial and legal questions about an article: prices, dispensing rules, co-payment status, packaging. The other family answers clinical questions about a substance: interactions, contraindications, dosing, active ingredient dossiers. The first is the ABDA-Artikelstamm and its variants. The second is the ABDA-Datenbank family, published today as ABDADatenbank² with modules for finished medicinal products, medication safety, the pharmaceutical substance list and active substance dossiers, alongside ABDAmed² and the consumer-facing ABDATA Laiendaten.
Set out as a hierarchy, the structure is unambiguous.
| Name | What it is | Legal form | Sits where | Sells data? |
|---|---|---|---|---|
| ABDA | Federal union of German pharmacists' associations | Registered association (e.V.) | Top of the structure, Berlin | No |
| Avoxa | Media, events and data group | GmbH, subsidiary of ABDA | Directly below ABDA, Eschborn | Yes, through ABDATA |
| ABDATA | Pharma-Daten-Service, database producer | Business division, not a separate entity | Inside Avoxa | Yes, licensed to software vendors |
| ABDA-Artikelstamm | Article master file: prices, dispensing and reimbursement law | Product | Produced by ABDATA | Licensed product |
| ABDA-Datenbank | Clinical and pharmaceutical database family | Product | Produced by ABDATA | Licensed product |
Read top to bottom, that is: an association, its company, that company's division, and that division's products. The products carry the association's name for brand and provenance reasons, not because the association produces them.
The confusion is not carelessness. Four things conspire.
First, the acronym no longer means what it says. ABDA originally stood for Arbeitsgemeinschaft der Berufsvertretungen Deutscher Apotheker. The organisation later renamed itself Bundesvereinigung Deutscher Apothekerverbaende but kept the established letters. So the acronym does not expand to the current name, and anyone trying to derive meaning from the letters is decoding a name that was retired decades ago.
Second, ABDATA looks like a compound of ABDA plus data, and it more or less is. That reads as though ABDATA were simply ABDA's data department. It is not. There are two corporate layers in between, and the one in the middle, Avoxa, has a name that shares no letters with either.
Third, product names and organisation names collide. The ABDA-Artikelstamm and the ABDA-Datenbank are products of ABDATA, but they are branded ABDA. A tender document that asks for "ABDA data" could reasonably mean the article master file, the clinical database family, or both, and the answer changes what you procure.
Fourth, the layer everyone forgets is IFA. The commercial and logistical base data in the article master file does not originate with ABDATA at all. It is reported by suppliers to IFA GmbH, the Informationsstelle fuer Arzneispezialitaeten in Frankfurt, founded in 1987, which issues the Pharmazentralnummer (PZN), the eight-digit identifier that keys almost every German pharmaceutical transaction. IFA's shareholders include ABDA alongside the industry association BPI and the wholesalers' association PHAGRO. ABDATA takes that supplier-reported data and editorially enriches it. So there is a further upstream body, part-owned by ABDA, feeding the data that ABDATA refines.
"I think we are getting lost here. Especially when even people like us, who know this area, lose track." Employee at an international aid organisation, customer interview, translated from German
Short version, with the detail deliberately left to the companion articles.
A useful heuristic: if the question is what does this cost, may it be dispensed, who reimburses it, you are in article master territory. If the question is may this patient take it, with what, at what dose, you are in clinical database territory. The two answer different questions and are licensed separately.
ABDATA is one producer among several, and no single layer answers a full professional question on its own. The German landscape stacks roughly like this:
| Layer | Who holds it | What it answers |
|---|---|---|
| Identification and logistics | IFA GmbH (PZN and supplier-reported base data) | Which package is this, who supplies it |
| Commercial and pharmaceutical law | ABDATA, article master products | What does it cost, may it be dispensed, is it reimbursed |
| Clinical and scientific | ABDATA clinical database family, and competing compendia such as Gelbe Liste Pharmindex and Rote Liste | Interactions, contraindications, dosing |
| Regulatory | BfArM and the Paul-Ehrlich-Institut, EMA at EU level | Authorisation status, product information, supply shortage reports |
| Reimbursement policy | G-BA and the health insurance funds | Benefit assessment, substitution and discount contracts |
| Cross-border | National authorities and national compendia per country | Is there an equivalent product in another market |
Most real questions cut across several of these rows at once. Finding a supply alternative for a shortage, for example, touches identification, clinical equivalence, regulatory status and, if the German market is dry, another country's data entirely. Each of those layers is maintained by a different body on a different update cycle, and the join between them is left to whoever is asking.
That is the work pharmazie.com is built to remove. It brings the ABDA-Artikelstamm together with more than 25 pharmaceutical databases in a single search, covering over 50,000 German and more than 120,000 international products across more than 50 countries, and DACON has maintained this data since 1989. For cross-layer and cross-border questions in the DACH region and beyond, it is the most complete single answer available, rather than a substitute for any one licensed source.
If you remember one thing, make it the ownership chain: ABDA the association owns Avoxa the company, Avoxa runs ABDATA the data service, and ABDATA produces the databases that carry the ABDA name.
Two consequences follow. When a specification, tender or integration document says "ABDA data", ask which product is meant, because the article master and the clinical database family are different licences answering different questions. And when a colleague says the data comes from ABDA, they are right about the brand and imprecise about the source: the commercial base data is reported to IFA, editorially enriched by ABDATA, and published under the ABDA name by a company most people outside Germany have never heard of.
This content is intended for healthcare professionals and does not constitute medical advice. Last reviewed: July 2026.
